Randomized controlled Clinical Trial of Ayurveda Treatment Protocol with spice mix tablet (Tulsimmune) for management of SARS-CoV-2 Infection (COVID-19)â??.

Suraj Ayurveda Clinic and Research center0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Age Eligible for Study:18 Years to 75, male female
•2.Subject must meet the WHO/MOHFW India /ICMR Criteria having symptoms of SARS CoV2 described in WHO Report/groups described by MOHFW India, (Group B,C,D,E mainly)
•3.Quarantine/non hospitalized or hospitalized AND Fulfills WHO case definition, including a positive PCR for COVID-19 from any specimen (e.g. respiratory, blood, urine, stool, other bodily fluid) and other analysis.

•1.Active indication and use for one of the investigational products (e.g. HIV positive or active hepatitis B if antiretroviral agents were used )
•2.Allergy or other contraindication or one of the investigational products
•3.In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments.
•4.Participant with any immunosuppressive condition or hematological disease
•5.Participation in any other A.S.U and H protocol
•6.Pregnant woman and lactating mother

发起方

Suraj Ayurveda Clinic and Research center